Suggestions
Andrew Forman
President at Forman Foresight 2020
Professional Background
Andrew Forman is a seasoned professional with over 25 years of extensive experience in the pharmaceutical industry, where he has established a reputation as a dynamic leader and expert. With a solid foundation in sales, marketing, and business development, Andrew has successfully navigated the complexities of pharmaceuticals from various vantage points, including the corporate world and Wall Street. For a noteworthy 12 years, he was a sell-side analyst on Wall Street, specializing in the specialty pharmaceutical sector, where he provided invaluable insights and analyses that informed investment decisions for major financial institutions.
His talents and expertise in the pharmaceutical arena were recognized widely in 2005 when he was honored as the #1 Pharmaceutical Analyst by both the Wall Street Journal and Forbes. These accolades stand as a testament to his analytical prowess and deep industry knowledge, showcasing his ability to dissect market trends and provide actionable recommendations to clients and stakeholders alike.
Education and Achievements
Andrew's educational background is quite impressive, having obtained both his MBA in Business from the prestigious Columbia Business School and a BA in Physiology from Rutgers University. This combination of business acumen and scientific understanding underpins his success in the pharmaceutical sector, allowing him to bridge the gap between advanced medical science and strategic business management.
As a professional, Andrew's achievements are substantial and diverse. As the President at Forman Foresight since 2020, he has adeptly guided strategic initiatives and growth in his organization, fostering innovative approaches to business challenges in the life sciences sector. Prior to this, Andrew shaped the future of various organizations through significant roles:
- He was a Global Life Sciences Sector Resident in Transaction Advisory Services at Ernst & Young, where he contributed his expertise to facilitate transactions within the life sciences industry, focusing on growth strategies and operational efficiencies.
- As Managing Director at WR Hambrecht, he played a crucial role in leading teams in the analysis and execution of major strategic transactions.
- With a previous stint as an Executive Director at both UBS and UBS Warburg Dillon Read, Andrew contributed to high-impact projects that positioned firms as leaders in the investment banking landscape.
- He also held a pivotal role as the Director of Business Development at Cygnus, where he drove initiatives that resulted in tangible growth and innovation.
- Earlier in his career, he laid the groundwork for his robust pharmaceutical career as a Pharmaceutical Sales Representative at Bristol-Myers Squibb and engaged in business development at Du Pont.
Artistic Pursuit
In addition to his stellar career in the pharmaceutical industry, Andrew is also passionate about the arts as a post-industrial impressionist painter. This creative outlet speaks to his multifaceted personality and ability to think outside the box, fostering his innovative approach to business challenges. Andrew's artwork reflects his nuanced understanding of both the human experience and the complexities of modern life, allowing him to express his insights through a different medium.
Conclusion
In summary, Andrew Forman's deep-seated experience in the pharmaceutical industry, complemented by his educational credentials and diverse roles within corporate America, position him as a leader and innovator in the field. His accolades as a top pharmaceutical analyst and his passion for art illustrate a well-rounded character whose contributions extend beyond traditional business boundaries, aiming to make a meaningful impact in both science and creativity.